|
Main
|
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
17 April 2023 |
|
Main ID: |
NCT03269084 |
|
Date of registration:
|
30/08/2017 |
|
Prospective Registration:
|
No |
|
Primary sponsor: |
|
|
Public title:
|
Type 1 Diabetes Prediction and Prevention (DIPP) Study
DIPP |
|
Scientific title:
|
Type 1 Diabetes Prediction and Prevention (DIPP) Study |
|
Date of first enrolment:
|
November 7, 1994 |
|
Target sample size:
|
17000 |
|
Recruitment status: |
Recruiting |
|
URL:
|
https://clinicaltrials.gov/show/NCT03269084 |
|
Study type:
|
Observational |
|
Study design:
|
|
|
Phase:
|
|
|
|
Countries of recruitment
|
|
Finland
| | | | | | | |
|
Contacts
|
|
Name:
|
Kalle Kurppa, MD PhD |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
Tampere University |
|
|
Name:
|
Johanna Lempainen, MD PhD |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
University of Turku |
|
|
Name:
|
Jorma Toppari, MD PhD |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
University of Turku, Turku University Hospital |
|
|
Name:
|
Riitta Veijola, MD PhD |
|
Address:
|
|
|
Telephone:
|
+358407422328 |
|
Email:
|
riitta.veijola@oulu.fi |
|
Affiliation:
|
|
|
|
Name:
|
Mikael Knip, MD PhD |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
University of Helsinki, Tampere University Hospital |
|
|
Name:
|
Heikki Hyöty, MD PhD |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
Tampere University |
|
|
Name:
|
Riitta Veijola, MD PhD |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
University of Oulu, Oulu University Hospital |
| | |
|
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- Newborn babies with HLA-conferred genetic susceptibility to type 1 diabetes born in
three University Hospitals in Finland
Exclusion Criteria:
- Newborn babies without HLA-conferred genetic susceptibility to type 1 diabetes
Age minimum:
N/A
Age maximum:
N/A
Gender:
All
|
|
Health Condition(s) or Problem(s) studied
|
|
Type 1 Diabetes Mellitus
|
|
Intervention(s)
|
|
Other: No intervention. DIPP is an observational study.
|
|
Primary Outcome(s)
|
|
Clinical diagnosis of type 1 diabetes
[Time Frame: December 31, 2021]
|
|
Positivity for at least one islet autoantibody
[Time Frame: December 31, 2021]
|
|
Secondary ID(s)
|
|
1-SRA-2016-342-M-R
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|
Results
|
|
Results available:
|
|
|
Date Posted:
|
|
|
Date Completed:
|
|
|
URL:
|
|
|
|